US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Primary Sclerosing Cholangitis - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... information on the therapeutic development for Primary Sclerosing Cholangitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Pyelonephritis - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with ...  |  read more...
USD 2,000
Iron Deficiency Anemia - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Phenylketonuria (PKU) - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... therapeutic development for Phenylketonuria (PKU), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Anaplastic Thyroid Cancer - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... information on the therapeutic development for Anaplastic Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Polycystic Ovarian Syndrome - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Rectal Cancer - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... therapeutic development for Rectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Inflammatory Bowel Disease Drugs Industry Report 2015
7/31/2015 | published by: QYResearch Group
... industry including definitions, classifications, applications and industry chain structure.The Inflammatory Bowel Disease Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and ...  |  read more...
USD 2,800
Global Systemic Lupus Erythematosus (SLE) Drugs Industry Report 2015
7/31/2015 | published by: QYResearch Group
... of the industry including definitions, classifications, applications and industry chain structure.The Systemic Lupus Erythematosus (SLE) Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...  |  read more...
USD 2,800
Global Peptide Synthesizer Industry Report 2015
8/4/2015 | published by: QYResearch Group
... applications and industry chain structure.The Peptide Synthesizer market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as ...  |  read more...
USD 2,800
Brain Metastasis - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... therapeutic development for Brain metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Trauma - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... Trauma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Eosinophilic Esophagitis - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... therapeutic development for Eosinophilic Esophagitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Acute Ischemic Stroke - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... information on the therapeutic development for Acute Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Otitis Media - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and Lean Biomanufacturing System
8/1/2015 | published by: CHI Insight Pharma Reports
... a more reactive and dynamic biomanufacturing approach than is the current industry standard. Biomanufacturing is common practice in the life sciences industry and has been continually developed and improved for the last two decades. However, ...  |  read more...
USD 1,995
Influenza B Infections - Pipeline Review, H2 2015
7/29/2015 | published by: Global Markets Direct
... information on the therapeutic development for Influenza B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Contact Dermatitis - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... therapeutic development for Contact dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Status Epilepticus - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... therapeutic development for Status Epilepticus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Acute Sensorineural Hearing Loss - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015
7/22/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Chronic Stable Angina Global Clinical Trials Review, H1, 2015
6/25/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Chronic Stable Angina. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Huntington's Disease - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... therapeutic development for Huntington's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with comparative analysis at various stages, therapeutics assessment by ...  |  read more...
USD 2,000
1    3    5  6  7  8  9  10